Table. Catch-up schedule for 20vPCV for children aged <5 years who are either Aboriginal and Torres Strait Islander (including those living in ACT, NSW, Tas or Vic who were born on or after 1 March 2025), or have a risk condition(s) for pneumococcal disease
Children and adults with the risk conditions listed below are at increased risk of pneumococcal disease and are recommended by ATAGI to receive additional doses of pneumococcal vaccine.
Common adverse events following immunisation (AEFI) are usually mild and temporary. They usually occur in the first few days after vaccination. Specific treatment is not usually needed.
